InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

Current share price for MPL : $4.980 0.01 (0.20%)+

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13,798 FY26 Full Year - Key Dates 15 May 2026 8:25AM $4.590 $5.010 risen by 9.15%
$13,798 Medibank shares business update and customer insights 5 May 2026 7:35AM $4.730 $5.010 risen by 5.92%
$13,798 Change in substantial holding 30 Apr 2026 4:05PM $4.665 $5.010 risen by 7.40%
$13,798 Notification of cessation of securities - MPL 8 Apr 2026 8:43AM $4.440 $5.010 risen by 12.84%
$13,798 Notification regarding unquoted securities - MPL 7 Apr 2026 8:30AM $4.440 $5.010 risen by 12.84%
$13,798 Becoming a substantial holder 25 Mar 2026 8:17AM $4.400 $5.010 risen by 13.86%
$13,798 2022 cybercrime event - consumer class action 20 Mar 2026 5:30PM $4.210 $5.010 risen by 19%
$13,798 Change of Director's Interest - P Everingham, J Hey 4 Mar 2026 9:10AM $4.400 $5.010 risen by 13.86%
$13,798 Change of Director's Interest - Lisa McIntyre 2 Mar 2026 8:32AM $4.380 $5.010 risen by 14.38%
$13,798 Change in substantial holding 23 Feb 2026 4:28PM $4.450 $5.010 risen by 12.58%
$13,798 HY26 Results - Investor Presentation 19 Feb 2026 7:41AM $4.790 $5.010 risen by 4.59%
$13,798 HY26 Results - Media Release 19 Feb 2026 7:39AM $4.790 $5.010 risen by 4.59%
$13,798 Dividend/Distribution - MPL 19 Feb 2026 7:37AM $4.790 $5.010 risen by 4.59%
$13,798 HY26 Results - Appendix 4D and Financial Report 19 Feb 2026 7:35AM $4.790 $5.010 risen by 4.59%
$13,798 Medibank announces 2026 premium change 17 Feb 2026 7:05PM $4.520 $5.010 risen by 10.84%
$13,798 Re-presentation of segment results and terminology changes 13 Feb 2026 3:05PM $4.455 $5.010 risen by 12.46%
$13,798 Final Director's Notice - Jay Weatherill 6 Jan 2026 8:54AM $4.750 $5.010 risen by 5.47%
$13,798 Notification of cessation of securities - MPL 6 Jan 2026 8:28AM $4.750 $5.010 risen by 5.47%
$13,798 Change of Director's Interest - David Koczkar 29 Dec 2025 8:40AM $4.770 $5.010 risen by 5.03%
$13,798 Change of Director's Interest - David Koczkar 19 Dec 2025 4:33PM $4.760 $5.010 risen by 5.25%
$13,798 Notification regarding unquoted securities - MPL 19 Dec 2025 9:57AM $4.780 $5.010 risen by 4.81%
$13,798 FY26 Half Year - Key Dates 12 Dec 2025 8:25AM $4.670 $5.010 risen by 7.28%
$13,798 Initial Director's Interest Notice - J Hey, L McIntyre 26 Nov 2025 9:21AM $4.730 $5.010 risen by 5.92%
$13,798 Final Director's Interest Notice - D Fagan, L Nicholls 26 Nov 2025 9:19AM $4.730 $5.010 risen by 5.92%
$13,798 Results of 2025 Annual General Meeting 19 Nov 2025 1:16PM $4.750 $5.010 risen by 5.47%

1 - 25 of 487 results

Page 1 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.